Access cutting-edge cutaneous sarcoidosis treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access cutaneous sarcoidosis specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cutaneous sarcoidosis treatment provided free
This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.
Sponsor: Priovant Therapeutics, Inc.
Check if you qualify for this cutaneous sarcoidosis clinical trial in Philadelphia, PA
If you're searching for cutaneous sarcoidosis treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cutaneous sarcoidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.